Vaxart adjourns annual meeting to June 2; seeks more votes for reverse stock split to regain Nasdaq compliance

Vaxart, Inc.

Annual meeting adjourned to June 2, 2025 at 8:30 a.m. PT; proxies representing ~67% of shares already submitted.
Board urges approval of Proposal 2 (reverse stock split) to meet Nasdaq minimum bid price requirement.
Stockholders of record as of March 26, 2025 who haven't voted must do so by 11:59 p.m. ET on June 1.
Stockholders who previously voted against the reverse split can change their vote in favor.
Reasons cited: higher stock price may attract investors, analysts, and help retain employees.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.